XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Total revenue $ 13,690 $ 5,362 $ 20,857 $ 6,071
Revenue        
Total revenue 13,690 5,362 20,857 6,071
Operating expenses        
Cost of product revenue 1,025 0 1,583 0
Cost of product revenue - intangible asset amortization 258 0 517 0
Research and development 124,187 128,339 250,870 259,315
Selling, general and administrative 75,490 54,228 148,980 108,179
Total operating expenses 200,960 182,567 401,950 367,494
Loss from operations (187,270) (177,205) (381,093) (361,423)
Other income (expense), net 10,357 760 19,594 (3,408)
Net loss (176,913) (176,445) (361,499) (364,831)
Foreign currency translation adjustment (34) 0 (65) 0
Unrealized gain (loss) on available-for-sale investments 26 (909) 2,069 (5,711)
Comprehensive loss $ (176,921) $ (177,354) $ (359,495) $ (370,542)
Basic net loss per share (USD per share) $ (3.04) $ (3.18) $ (6.22) $ (6.57)
Diluted net loss per share (USD per share) $ (3.04) $ (3.18) $ (6.22) $ (6.57)
Weighted average common shares outstanding, basic (shares) 58,232,084 55,552,438 58,131,954 55,510,649
Weighted average common shares outstanding, diluted (shares) 58,232,084 55,552,438 58,131,954 55,510,649
Product Revenue        
Total revenue $ 13,365 $ 0 $ 19,656 $ 0
Revenue        
Total revenue 13,365 0 19,656 0
License and Collaboration Revenue        
Total revenue 325 5,362 1,201 6,071
Revenue        
Total revenue $ 325 $ 5,362 $ 1,201 $ 6,071